Vaccines from Pfizer, Moderna, AstraZeneca and Janssen have little impact on the stock market, analysts say. In innovative medicines, the story is different.
The impact of covid vaccines on the four pharmaceuticals authorized by the European Medicines Agency (EMA) in stock terms is small, despite the profits obtained from the massive sale of doses, say most analysts contacted by JN/Dinheiro Vivo.
Innovative drugs to fight chronic diseases, such as cancer, developed by Pfizer, Moderna, AstraZeneca and by Janssen, a Johnson & Johnson company, have more impact on the stock market of companies.
Read more in Jornal de Notícias